SynthesisBMC cancer2022

Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis.

Teng-Kai Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.